Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases Cologne, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Brain. 2023 Feb 13;146(2):534-548. doi: 10.1093/brain/awac278.
We describe an autosomal dominant disorder associated with loss-of-function variants in the Cell cycle associated protein 1 (CAPRIN1; MIM*601178). CAPRIN1 encodes a ubiquitous protein that regulates the transport and translation of neuronal mRNAs critical for synaptic plasticity, as well as mRNAs encoding proteins important for cell proliferation and migration in multiple cell types. We identified 12 cases with loss-of-function CAPRIN1 variants, and a neurodevelopmental phenotype characterized by language impairment/speech delay (100%), intellectual disability (83%), attention deficit hyperactivity disorder (82%) and autism spectrum disorder (67%). Affected individuals also had respiratory problems (50%), limb/skeletal anomalies (50%), developmental delay (42%) feeding difficulties (33%), seizures (33%) and ophthalmologic problems (33%). In patient-derived lymphoblasts and fibroblasts, we showed a monoallelic expression of the wild-type allele, and a reduction of the transcript and protein compatible with a half dose. To further study pathogenic mechanisms, we generated sCAPRIN1+/- human induced pluripotent stem cells via CRISPR-Cas9 mutagenesis and differentiated them into neuronal progenitor cells and cortical neurons. CAPRIN1 loss caused reduced neuronal processes, overall disruption of the neuronal organization and an increased neuronal degeneration. We also observed an alteration of mRNA translation in CAPRIN1+/- neurons, compatible with its suggested function as translational inhibitor. CAPRIN1+/- neurons also showed an impaired calcium signalling and increased oxidative stress, two mechanisms that may directly affect neuronal networks development, maintenance and function. According to what was previously observed in the mouse model, measurements of activity in CAPRIN1+/- neurons via micro-electrode arrays indicated lower spike rates and bursts, with an overall reduced activity. In conclusion, we demonstrate that CAPRIN1 haploinsufficiency causes a novel autosomal dominant neurodevelopmental disorder and identify morphological and functional alterations associated with this disorder in human neuronal models.
我们描述了一种常染色体显性遗传疾病,其与细胞周期相关蛋白 1(CAPRIN1;MIM*601178)的功能丧失变异有关。CAPRIN1 编码一种普遍存在的蛋白质,可调节神经元 mRNA 的运输和翻译,这些 mRNA 对突触可塑性至关重要,还可调节多种细胞类型中细胞增殖和迁移所需的蛋白质编码 mRNA。我们鉴定了 12 例具有功能丧失 CAPRIN1 变异的病例,其神经发育表型特征为语言障碍/言语迟缓(100%)、智力障碍(83%)、注意缺陷多动障碍(82%)和自闭症谱系障碍(67%)。受影响的个体还存在呼吸问题(50%)、肢体/骨骼异常(50%)、发育迟缓(42%)、喂养困难(33%)、癫痫发作(33%)和眼科问题(33%)。在患者来源的淋巴母细胞和成纤维细胞中,我们发现野生型等位基因的单等位基因表达,并出现与半剂量相符的转录本和蛋白质减少。为了进一步研究致病机制,我们通过 CRISPR-Cas9 诱变生成了 sCAPRIN1+/- 人诱导多能干细胞,并将其分化为神经元祖细胞和皮质神经元。CAPRIN1 缺失导致神经元过程减少、神经元组织整体紊乱和神经元退行性增加。我们还观察到 CAPRIN1+/- 神经元中的 mRNA 翻译发生改变,这与其作为翻译抑制剂的功能一致。CAPRIN1+/- 神经元还表现出钙信号传导受损和氧化应激增加,这两种机制可能直接影响神经元网络的发育、维持和功能。根据在小鼠模型中观察到的结果,通过微电极阵列对 CAPRIN1+/- 神经元的活性进行测量,结果表明 CAPRIN1+/- 神经元的尖峰频率和爆发率较低,整体活性降低。总之,我们证明 CAPRIN1 杂合不足导致一种新的常染色体显性神经发育障碍,并在人类神经元模型中确定了与该疾病相关的形态和功能改变。